Sara Lazzari

Dr. Sara Lazzari

DISCOG, University of Padua, Padua, Italy
+1
orcid
PhD Student University of Padua; HPB and Transplant Surgeon

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 January 2023 in Cancers
Verified
Journal Article
Open access
PDF file
JLJacopo Lanari
Jacopo Lanari
SCSilvia Caregari
Silvia Caregari
IBIlaria Billato
Ilaria Billato
Enrico GringeriEnrico Gringeri
Enrico Gringeri
FDFrancesco D'Amico
Francesco D'Amico
Umberto CilloUmberto Cillo
Umberto Cillo
In the context of spreading interest in textbook outcome (TO) evaluation in different fields, we aimed to investigate an uncharted procedure, that is, laparoscopic microwave ablation (MWA) for hepatocellular carcinoma (HCC). Absence of post-MWA complications, a hospital stay of three days, no mortality nor readmission within 30 days, and complete response of the target lesion at post-MWA CT scan defined TO achievement. Patients treated between January 2014 and March 2021 were retrospectively reviewed, and of the 521 patients eligible for the study, 337 (64.7%) fulfilled all the quality indicators to achieve the TO. The absence of complications was the main limiting factor for accomplishing TO. At multivariable analysis, Child–Pugh B cirrhosis, age of more than 70 years old, three nodules, and MELD score ≥ 15 were associated with decreased probabilities of TO achievement. A score based on these factors was derived from multivariable analysis, and patients were divided into three risk groups for TO achievement. At survival analysis, overall survival (OS) was significantly (p = 0.001) higher in patients who achieved TO than those who did not. Moreover, OS evaluation in the three risk groups showed a trend coherent with TO achievement probability. The present study, having assessed the first TO for laparoscopic MWA for HCC, encourages further broader consensus on its definition and, on its basis, on the development of clinically relevant tools for managing treatment allocation.

1 January 2021
Verified
Journal Article
Closed access
BPB Pessia
B Pessia
LRL Romano
L Romano
FCF Carlei
F Carlei
Sara LazzariSara Lazzari
Sara Lazzari
VVV Vicentini
V Vicentini
MSM Schietroma
M Schietroma

10 December 2024 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
Umberto CilloUmberto Cillo
Umberto Cillo
SCSilvia Caregari
Silvia Caregari
MBMatteo Barabino
Matteo Barabino
IBIlaria Billato
Ilaria Billato
AMAndrea Marchini
Andrea Marchini
RSRoberto Santambrogio
Roberto Santambrogio

1 January 2022 in Surgery, Gastroenterology and Oncology
Verified
Journal Article
Open access
PDF file
MSMario Schietroma
Mario Schietroma
LRLucia Romano
Lucia Romano
Sara LazzariSara Lazzari
Sara Lazzari
BPBeatrice Pessia
Beatrice Pessia
Antonella MatteiAntonella Mattei
Antonella Mattei
AGAntonio Giuliani
Antonio Giuliani

4 October 2025 in HPB
Verified
Journal Article
Closed access
FDF.E. D'AMico
F.E. D'AMico
SMS. Mema
S. Mema
RAR. Alessandris
R. Alessandris
IBI. Billato
I. Billato
Sara LazzariSara Lazzari
Sara Lazzari
UCU. Cillo
U. Cillo

1 October 2025 in Digestive and Liver Disease
Verified
Journal Article
Closed access
EGE. Gringeri
E. Gringeri
AFA. Furlanetto
A. Furlanetto
DPD. Pinelli
D. Pinelli
SGS. Gruttadauria
S. Gruttadauria
ALA. Lauterio
A. Lauterio
UCU. Cillo
U. Cillo